---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-020805"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2026-05-12T20:04:46+00:00"
generated_at: "2026-05-12T21:37:05.750209+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuwellis Q1 net sales $2.4M (+26% YoY); gross margin 70.1%; net loss $4.3M

## Summary
- Net sales $2.4M, up 26% from $1.9M YoY; gross margin 70.1% (improved 14% YoY).
- Net loss $4.3M; operating expenses $6.0M (up from $4.1M) due to sales headcount.
- Cash $2.2M, no debt as of March 31, 2026.
- Acquired Rendiatech (kidney-function monitoring); appointed Carisa Schultz as CFO.
- Appointed Martin J. Emerson and David A. McDonald to Board; new patents and TX territory.

## SEC filing metadata
- accession: 0001140361-26-020805
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2026-05-12T20:04:46+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036126020805/0001140361-26-020805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036126020805/ef20073181_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-020805
- JSON: https://secwatch.observer/filing/0001140361-26-020805.json
- Plain text: https://secwatch.observer/filing/0001140361-26-020805.txt

## Key facts
- Earnings Releases
  Nuwellis, Inc. reported the first quarter ended March 31, 2026 results: revenue $2.4 million, net income approximately $4.3 million.
  - Period: the first quarter ended March 31, 2026
  - Revenue: $2.4 million
  - Net income: approximately $4.3 million
  - Result: reported results
  source text: for patients with cardiorenal conditions, today reported financial results for the first quarter ended March 31, 2026. First Quarter and Recent Highlights: • Net sales were $2.4 million, a 26% increase compared to the prior-year period • Gross margin improved to 70.1%, reflecting improved pricing, product mix, and the transition to contract manufacturing •
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506492/000114036126020805/0001140361-26-020805-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.